65,437 trials
Mantle Cell Lymphoma
Primary: Percentage of Participants Who Achieved an Overall Response According to the Independent Review Committee (IRC) — 29.9 percentage of participants
Myopia
Primary: Subjective Happiness With Correction Type — 4.92; 4.50 Units on a Scale
Overweight · Eating Disorders
Primary: Weight Loss — 6.15; 3.61 lbs
Breast Neoplasms
Primary: Estimates of Effect of Selectively Upgrading BIRADS Category 3 and Downgrading BIRADS 4a Masses Based on SWE Features. Overall Specificity and Sensitivity of BI-RADS…
Heart Failure
Primary: Change in Citrate Synthase Activity as an Estimate of Mitochondrial Activity — -0.3; 0.07 micromole/min/wet weight
Parkinson Disease
Primary: Patient Preference — 17; 31; 13 participants
Diabetes
Primary: MAD Mean Absolute Value of the Difference Between Blood Glucose Meter (BGMS) Results and Corresponding YSI Blood Glucose (BG) Results in the Low BG Range(<70 mg/dL)…
Glaucoma
Primary: Ocular Discomfort — 25.5 mm
Prostate Cancer
Primary: Patient Bother From Injection Site Burning and/or Stinging — 23.87; 5.84 units on a scale
Anti- VGF Inhibitor · Diabetic Macular Edema · Diabetic Retinopathy
Primary: Incidence of Ocular and Non-Ocular Adverse Events (AEs) — 10; 8 participants
Severe Hypertriglyceridemia
Primary: Fasting Serum Triglycerides — -4.26; -25.94; -25.46; -30.86 Percent change from baseline — p=0.005
Attention-Deficit Hyperactivity Disorder
Primary: Change From Baseline to Endpoint in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Total Attention Deficit-Hyperactivity Disorder (ADHD) Symptoms…
Breast Cancer
Primary: Change in Percent of Breast Epithelial Cells Staining Positive for Ki-67 — -1.2; -2.0 percentage of cells staining positive — p=0.71
Prostate Cancer
Primary: Overall Survival (OS) — NA; 77 weeks — p=0.0017
Hemophilia A
Primary: Area Under the Plasma Concentration Versus Time Curve From 0 to 48 Hours (AUC 0-48h). Chromogenic Assay — 1158; 1264 (IU·h)/dL — p=0.103